Document is current
Any future updates will be listed below
-
Authors
Manesh, Abi https://orcid.org/0000-0001-9970-9674
Walia, Kamini
Saiyed, Taslimarif https://orcid.org/0000-0002-8767-781X
Veeraraghavan, Balaji https://orcid.org/0000-0002-8662-4257
Paterson, David L.
- License Information
-
More Information
Article History
Received: 3 March 2026
Accepted: 20 July 2026
First Online: 31 July 2026
Ethics
Competing interests: Dr. David L Paterson reports receiving grants from Shionogi, Pfizer, Merck, BioVersys, bioMerieux, Johnson & Johnson, and Gilead and receiving honoraria from Shionogi, Merck, GSK, bioMerieux, Cepheid, Aurobac, Arrepath, Menarini, CARB-X, and the AMR Action Fund. No other potential competing interest relevant to this letter was reported. We did not receive any specific funding for this work. This work has not been presented anywhere else.
